A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non–Small Cell Lung Cancer

Published:2018-05 Issue:5 Volume:13 Page:699-706
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Toyooka Shinichi,Okumura Norihito,Nakamura Hiroshige,Nakata Masao,Yamashita Motohiro,Tada Hirohito,Kajiwara Shinsuke,Watanabe Naoki,Okada Morihito,Sakamoto Junichi,Aoe Motoi,Soh Junichi,Miyoshi Shinichiro,Hotta Katsuyuki,Matsuo Keitaro,Date Hiroshi

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference18 articles.

1. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;Arriagada;N Engl J Med,2004

2. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer;Winton;N Engl J Med,2005

3. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial;Douillard;Lancet Oncol,2006

4. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study groups;Strauss;J Clin Oncol,2008

5. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery;Wada;J Clin Oncol,1996

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Value of PERCIST for Locally Advanced Non-Small Cell Lung Cancer Treated with Preoperative Induction Therapy – A Multicenter Study in Japan;Cancer Management and Research;2024-07

2. Benefit of Adjuvant Chemotherapy for Patients Older Than 75 Years With Completely Resected p-Stage II-IIIA Non-Small-Cell Lung Cancer: A Retrospective Cohort Study Using Japanese Nationwide Real-World Data;CLIN LUNG CANCER;2024

3. Benefit of Adjuvant Chemotherapy for Patients Older Than 75 Years With Completely Resected p-Stage II-IIIA Non–Small-Cell Lung Cancer: A Retrospective Cohort Study Using Japanese Nationwide Real-World Data;Clinical Lung Cancer;2024-01

4. Is adjuvant chemotherapy for completely resected p-stage IA (>2 cm) and stage IB non-small-cell lung cancer beneficial for elderly patients? A large, retrospective cohort study based on real-world data from Japan;Japanese Journal of Clinical Oncology;2023-08-25

5. Oral uracil–tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early‐stage non‐small cell lung cancer patients;Cancer Medicine;2023-08-09